Aveanna Healthcare (AVAH) Stock Forecast, Price Target & Predictions
AVAH Stock Forecast
Aveanna Healthcare stock forecast is as follows: an average price target of $4.10 (represents a -9.09% downside from AVAH’s last price of $4.51) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
AVAH Price Target
The average price target for Aveanna Healthcare (AVAH) is $4.10 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $2.00. This represents a potential -9.09% downside from AVAH's last price of $4.51.
AVAH Analyst Ratings
According to 5 Wall Street analysts, Aveanna Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for AVAH stock is 1 'Strong Buy' (20.00%), 2 'Buy' (40.00%), 2 'Hold' (40.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Aveanna Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 09, 2024 | Ben Hendrix | RBC Capital | $5.00 | $4.87 | 2.67% | 10.86% |
| Nov 17, 2022 | - | Credit Suisse | $2.00 | $0.80 | 149.25% | -55.65% |
| Aug 19, 2022 | - | Barclays | $5.00 | $2.13 | 134.74% | 10.86% |
| Aug 15, 2022 | - | Raymond James | $6.00 | $2.14 | 180.37% | 33.04% |
| Jul 12, 2022 | David MacDonald | Truist Financial | $2.50 | $2.49 | 0.40% | -44.57% |
The latest Aveanna Healthcare stock forecast, released on Aug 09, 2024 by Ben Hendrix from RBC Capital, set a price target of $5.00, which represents a 2.67% increase from the stock price at the time of the forecast ($4.87), and a 10.86% increase from AVAH last price ($4.51).
Aveanna Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $5.00 | $5.00 |
| Last Closing Price | $4.51 | $4.51 | $4.51 |
| Upside/Downside | -100.00% | 10.86% | 10.86% |
In the current month, the average price target of Aveanna Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aveanna Healthcare's last price of $4.51. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 09, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Aug 09, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
| Nov 17, 2022 | Credit Suisse | - | Neutral | Downgrade |
| Nov 16, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
| Aug 19, 2022 | Barclays | Overweight | Overweight | Hold |
| Aug 15, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
Aveanna Healthcare's last stock rating was published by Deutsche Bank on Aug 09, 2024. The company gave AVAH a "Buy" rating, the same as its previous rate.
Aveanna Healthcare Financial Forecast
Aveanna Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $471.94M | $466.41M | $451.15M | $443.01M | $442.95M | $450.53M | - | $411.28M | $436.11M | $417.16M |
| Avg Forecast | $570.40M | $546.60M | $565.70M | $545.20M | $528.06M | $520.97M | $529.74M | $515.53M | $501.74M | $495.87M | $493.49M | $483.98M | $464.99M | $453.69M | $457.57M | $452.03M | $448.16M | $446.78M | $450.62M | $434.33M | $417.33M | $445.79M | $434.01M | $414.39M |
| High Forecast | $570.40M | $546.60M | $565.70M | $545.20M | $528.06M | $520.97M | $529.74M | $515.53M | $501.74M | $500.90M | $493.49M | $484.00M | $474.33M | $453.69M | $457.57M | $452.03M | $448.16M | $446.78M | $450.62M | $434.33M | $417.33M | $445.79M | $434.01M | $414.39M |
| Low Forecast | $570.40M | $546.60M | $565.70M | $545.20M | $528.06M | $520.97M | $529.74M | $515.53M | $501.74M | $490.96M | $493.49M | $483.95M | $459.36M | $453.69M | $457.57M | $452.03M | $448.16M | $446.78M | $450.62M | $434.33M | $417.33M | $445.79M | $434.01M | $414.39M |
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.03% | 1.01% | 0.99% | 0.98% | 1.04% | - | 0.92% | 1.00% | 1.01% |
Aveanna Healthcare's average Quarter revenue forecast for Sep 23 based on 3 analysts is $453.69M, with a low forecast of $453.69M, and a high forecast of $453.69M. AVAH's average Quarter revenue forecast represents a -3.87% decrease compared to the company's last Quarter revenue of $471.94M (Jun 23).
Aveanna Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-102.39M | $-8.09M | $24.37M | $7.56M | $14.29M | $24.27M | $22.48M | - | $20.07M | $31.57M | $36.93M |
| Avg Forecast | $36.26M | $34.74M | $35.96M | $34.65M | $33.57M | $33.11M | $33.67M | $32.77M | $31.89M | $31.52M | $31.37M | $42.13M | $29.56M | $28.84M | $29.09M | $38.30M | $10.97K | $28.40M | $28.64M | $34.82M | $26.53M | $28.34M | $27.59M | $31.65M |
| High Forecast | $36.26M | $34.74M | $35.96M | $34.65M | $33.57M | $33.11M | $33.67M | $32.77M | $31.89M | $31.84M | $31.37M | $50.56M | $30.15M | $28.84M | $29.09M | $45.96M | $13.17K | $28.40M | $28.64M | $41.78M | $26.53M | $28.34M | $27.59M | $37.99M |
| Low Forecast | $36.26M | $34.74M | $35.96M | $34.65M | $33.57M | $33.11M | $33.67M | $32.77M | $31.89M | $31.21M | $31.37M | $33.71M | $29.20M | $28.84M | $29.09M | $30.64M | $8.78K | $28.40M | $28.64M | $27.86M | $26.53M | $28.34M | $27.59M | $25.32M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.55% | -0.28% | 0.64% | 689.15% | 0.50% | 0.85% | 0.65% | - | 0.71% | 1.14% | 1.17% |
3 analysts predict AVAH's average Quarter EBITDA for Jun 23 to be $29.09M, with a high of $29.09M and a low of $29.09M. This is 19.33% upper than Aveanna Healthcare's previous annual EBITDA (Mar 23) of $24.37M.
Aveanna Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-102.39M | $25.60M | $-32.00M | $-237.78M | $24.30M | $-473.89M | $25.33M | - | $2.09M | $1.26M | $5.80M |
| Avg Forecast | $11.81M | $9.84M | $9.84M | $7.87M | $5.17M | $2.92M | $5.21M | $-285.85K | $576.63K | $-2.46M | $-4.03M | $6.61M | $-4.91M | $-4.29M | $-7.19M | $6.01M | $-4.20M | $7.25M | $11.51M | $5.47M | $21.94M | $23.23M | $19.98M | $4.97M |
| High Forecast | $11.81M | $9.84M | $9.84M | $7.87M | $5.17M | $2.92M | $5.21M | $-285.85K | $576.63K | $2.46M | $-4.03M | $7.94M | $-2.45M | $-4.29M | $-7.19M | $7.22M | $-4.20M | $7.25M | $11.51M | $6.56M | $21.94M | $23.23M | $19.98M | $5.96M |
| Low Forecast | $11.81M | $9.84M | $9.84M | $7.87M | $5.17M | $2.92M | $5.21M | $-285.85K | $576.63K | $-4.92M | $-4.03M | $5.29M | $-7.36M | $-4.29M | $-7.19M | $4.81M | $-4.20M | $7.25M | $11.51M | $4.37M | $21.94M | $23.23M | $19.98M | $3.98M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.84% | -3.56% | -5.32% | 56.65% | 3.35% | -41.17% | 4.63% | - | 0.09% | 0.06% | 1.17% |
Aveanna Healthcare's average Quarter net income forecast for Sep 23 is $-4.29M, with a range of $-4.29M to $-4.29M. AVAH's average Quarter net income forecast represents a -116.78% decrease compared to the company's last Quarter net income of $25.60M (Jun 23).
Aveanna Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $60.77M | $110.68M | $122.76M | $125.20M | $125.31M | - | $114.24M | $110.12M | $96.77M |
| Avg Forecast | $143.62M | $137.63M | $142.44M | $137.28M | $132.96M | $131.17M | $133.38M | $129.81M | $126.33M | $124.85M | $124.26M | $110.40M | $117.08M | $114.24M | $115.21M | $100.37M | $112.84M | $112.50M | $113.46M | $91.24M | $105.08M | $112.25M | $109.28M | $82.95M |
| High Forecast | $143.62M | $137.63M | $142.44M | $137.28M | $132.96M | $131.17M | $133.38M | $129.81M | $126.33M | $126.12M | $124.26M | $132.48M | $119.43M | $114.24M | $115.21M | $120.44M | $112.84M | $112.50M | $113.46M | $109.49M | $105.08M | $112.25M | $109.28M | $99.54M |
| Low Forecast | $143.62M | $137.63M | $142.44M | $137.28M | $132.96M | $131.17M | $133.38M | $129.81M | $126.33M | $123.62M | $124.26M | $88.32M | $115.66M | $114.24M | $115.21M | $80.29M | $112.84M | $112.50M | $113.46M | $72.99M | $105.08M | $112.25M | $109.28M | $66.36M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 0.98% | 1.09% | 1.10% | 1.37% | - | 1.02% | 1.01% | 1.17% |
Aveanna Healthcare's average Quarter SG&A projection for Jun 23 is $115.21M, based on 3 Wall Street analysts, with a range of $115.21M to $115.21M. The forecast indicates a 89.58% rise compared to AVAH last annual SG&A of $60.77M (Mar 23).
Aveanna Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.54 | $0.14 | $-0.17 | $-1.28 | $0.13 | $-2.56 | $0.14 | - | $0.01 | $0.01 | $0.03 |
| Avg Forecast | $0.06 | $0.05 | $0.05 | $0.04 | $0.03 | $0.01 | $0.03 | $-0.00 | - | $-0.01 | $-0.02 | $-0.05 | $-0.02 | $-0.02 | $-0.04 | $-0.06 | $-0.02 | $0.04 | $0.06 | $0.06 | $0.11 | $0.12 | $0.10 | $0.07 |
| High Forecast | $0.06 | $0.05 | $0.05 | $0.04 | $0.03 | $0.01 | $0.03 | $-0.00 | - | $0.01 | $-0.02 | $-0.05 | $-0.01 | $-0.02 | $-0.04 | $-0.06 | $-0.02 | $0.04 | $0.06 | $0.06 | $0.11 | $0.12 | $0.10 | $0.07 |
| Low Forecast | $0.06 | $0.05 | $0.05 | $0.04 | $0.03 | $0.01 | $0.03 | $-0.00 | - | $-0.03 | $-0.02 | $-0.05 | $-0.04 | $-0.02 | $-0.04 | $-0.06 | $-0.02 | $0.04 | $0.06 | $0.06 | $0.11 | $0.12 | $0.10 | $0.07 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 24.76% | -3.83% | 2.82% | 60.03% | 3.53% | -43.78% | 2.33% | - | 0.08% | 0.07% | 0.44% |
According to 3 Wall Street analysts, Aveanna Healthcare's projected average Quarter EPS for Sep 23 is $-0.02, with a low estimate of $-0.02 and a high estimate of $-0.02. This represents a -115.58% decrease compared to AVAH previous annual EPS of $0.14 (Jun 23).
Aveanna Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company | $42.33 | $82.33 | 94.50% | Buy |
| SGRY | Surgery Partners | $29.22 | $44.33 | 51.71% | Buy |
| OPCH | Option Care Health | $22.49 | $32.75 | 45.62% | Buy |
| EHAB | Enhabit | $7.63 | $10.25 | 34.34% | Hold |
| BKD | Brookdale Senior Living | $6.24 | $7.50 | 20.19% | Buy |
| INNV | InnovAge | $5.90 | $6.80 | 15.25% | Hold |
| SEM | Select Medical | $36.51 | $40.00 | 9.56% | Buy |
| PNTG | Pennant Group | $32.38 | $34.67 | 7.07% | Buy |
| ADUS | Addus HomeCare | $128.96 | $129.40 | 0.34% | Buy |
| UHS | Universal Health Services | $208.83 | $208.47 | -0.17% | Hold |
| EHC | Encompass Health | $100.23 | $97.00 | -3.22% | Buy |
| ENSG | Ensign Group | $153.39 | $148.20 | -3.38% | Buy |
| AVAH | Aveanna Healthcare | $4.51 | $4.10 | -9.09% | Buy |
AVAH Forecast FAQ
Is Aveanna Healthcare a good buy?
Yes, according to 5 Wall Street analysts, Aveanna Healthcare (AVAH) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 2 'Buy' recommendations, accounting for 60.00% of AVAH's total ratings.
What is AVAH's price target?
Aveanna Healthcare (AVAH) average price target is $4.1 with a range of $2 to $6, implying a -9.09% from its last price of $4.51. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Aveanna Healthcare stock go up soon?
According to Wall Street analysts' prediction for AVAH stock, the company can go down by -9.09% (from the last price of $4.51 to the average price target of $4.1), up by 33.04% based on the highest stock price target, and down by -55.65% based on the lowest stock price target.
Can Aveanna Healthcare stock reach $7?
AVAH's average twelve months analyst stock price target of $4.1 does not support the claim that Aveanna Healthcare can reach $7 in the near future.
What are Aveanna Healthcare's analysts' financial forecasts?
Aveanna Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.09B (high $2.09B, low $2.09B), average EBITDA is $133.12M (high $133.12M, low $133.12M), average net income is $13.01M (high $13.01M, low $13.01M), average SG&A $527.32M (high $527.32M, low $527.32M), and average EPS is $0.0661 (high $0.0661, low $0.0661). AVAH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.23B (high $2.23B, low $2.23B), average EBITDA is $141.61M (high $141.61M, low $141.61M), average net income is $39.37M (high $39.37M, low $39.37M), average SG&A $560.96M (high $560.96M, low $560.96M), and average EPS is $0.2 (high $0.2, low $0.2).
Did the AVAH's actual financial results beat the analysts' financial forecasts?
Based on Aveanna Healthcare's last annual report (Dec 2023), the company's revenue was $1.9B, beating the average analysts forecast of $1.83B by 3.66%. Apple's EBITDA was $21.85M, missing the average prediction of $125.78M by -82.63%. The company's net income was $-135M, beating the average estimation of $-10.379M by 1196.12%. Apple's SG&A was $0, missing the average forecast of $446.89M by -100.00%. Lastly, the company's EPS was $0, missing the average prediction of $-0.144 by -100.00%. In terms of the last quarterly report (Jun 2023), Aveanna Healthcare's revenue was $471.94M, beating the average analysts' forecast of $457.57M by 3.14%. The company's EBITDA was $-8.085M, missing the average prediction of $29.09M by -127.80%. Aveanna Healthcare's net income was $25.6M, missing the average estimation of $-7.189M by -456.06%. The company's SG&A was $0, missing the average forecast of $115.21M by -100.00%. Lastly, the company's EPS was $0.14, missing the average prediction of $-0.0365 by -483.36%